Thalidomide CAS 50-35-1: A Comprehensive Pharmaceutical Analysis

Explore the multifaceted applications, historical impact, and scientific insights into Thalidomide (CAS 50-35-1).

Get a Quote & Sample

Key Advantages of Thalidomide

Immunomodulatory Properties

Thalidomide's ability to modulate the immune system is key to its therapeutic applications, offering benefits in various inflammatory conditions and its use for thalidomide leprosy treatment.

Antineoplastic Activity

As an antineoplastic agent, thalidomide demonstrates efficacy against certain cancers, particularly its role in thalidomide uses multiple myeloma, by interfering with cancer cell growth.

Targeted Mechanism of Action

The drug's interaction with cereblon, a protein crucial for cellular processes, is central to understanding both its therapeutic effects and thalidomide teratogenic effects, driving research into its precise mechanism of action.

Key Applications

Multiple Myeloma Treatment

Thalidomide is a vital component in the treatment regimens for multiple myeloma, leveraging its antineoplastic properties to combat cancer cells.

Leprosy Complication Management

Historically and currently, thalidomide is used to manage inflammatory complications associated with leprosy, such as erythema nodosum leprosum, showcasing its role in dermatologic and infectious disease management.

Immunoregulation in Diseases

Its immunomodulatory effects are explored in various immune-related disorders, highlighting its broader therapeutic potential beyond cancer and infectious diseases.

Research and Development

Ongoing research into thalidomide analogues and its mechanism of action continues to uncover new therapeutic avenues and better understand its complex biological impact.